Comments

Eli Lilly Analyst Ratings

LLYNYSE

Logo brought to you by Benzinga Data

Trade with Public

$1054.29

-7.90-0.74%

At close: Dec 15, 4:00 PM EST

$1051.80

-2.49-0.24%

Pre-Market: 8:32 AM EST

Why is it moving?

Novo Nordisk Loses Momentum As Eli Lilly Pulls Ahead In Weight-Loss Wars

Overview News Earnings Options Guidance Dividends

Analyst Ratings

Insider Trades Short Interest Government Trades Stock Report

Consensus Rating¹

Buy

Highest Price Target¹

$1500.00

Lowest Price Target¹

$700.00

Consensus Price Target¹

$1030.93

Eli Lilly Analyst Ratings and Price Targets | NYSE:LLY | Benzinga

Eli Lilly and Co has a consensus price target of $1030.93 based on the ratings of 29 analysts. The high is $1500 issued by Citigroup on November 12, 2025. The low is $700 issued by HSBC on August 27, 2025. The 3 most-recent analyst ratings were released by B of A Securities, Wells Fargo, and BMO Capital on December 15, 2025, December 10, 2025, and December 4, 2025, respectively. With an average price target of $1222.67 between B of A Securities, Wells Fargo, and BMO Capital, there's an implied 16.25% upside for Eli Lilly and Co from these most-recent analyst ratings.

Analyst Trends and Forecast

Aug

Sep

Oct

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Analyst Firms Making Recommendations¹

B of A Securities

Wells Fargo

BMO Capital

Morgan Stanley

Bernstein

¹calculated from analyst ratings

Analyst Ratings for Eli Lilly

					Get Alert
Dec 15, 2025	20.56%	Tim AndersonB of A Securities 64%	1.27K 1.29K	Previous Buy Current Buy	Get Alert
Dec 10, 2025	14.09%	Mohit BansalWells Fargo 68%	1.1K 1.2K	Previous Overweight Current Overweight	Get Alert
Dec 4, 2025	14.09%	Evan SeigermanBMO Capital 66%	1.1K 1.2K	Previous Outperform Current Outperform	Get Alert
Nov 24, 2025	22.65%	Terence FlynnMorgan Stanley 69%	1.17K 1.29K	Previous Overweight Current Overweight	Get Alert
Nov 24, 2025	23.6%	Courtney BreenBernstein 11%	1.1K 1.3K	Previous Outperform Current Outperform	Get Alert
Nov 19, 2025	12.38%	Robyn KarnauskasTruist Securities 54%	1.04K 1.18K	Previous Buy Current Buy	Get Alert
Nov 18, 2025	9.34%	Chris SchottJP Morgan 65%	1.05K 1.15K	Previous Overweight Current Overweight	Get Alert
Nov 13, 2025	11.33%	Terence FlynnMorgan Stanley 69%	1.09K 1.17K	Previous Overweight Current Overweight	Get Alert
Nov 12, 2025	42.61%	Peter VerdultCitigroup 28%	1.25K 1.5K	Previous Buy Current Buy	Get Alert
Nov 10, 2025	-9.68%	Ilya ZubkovFreedom Capital Markets 67%	750 950	Previous Buy Current Hold	Get Alert
Nov 10, 2025	4.96%	David RisingerLeerink Partners 71%	886 1.1K	Previous Market Perform Current Outperform	Get Alert
Nov 7, 2025	2.68%	Trung HuynhUBS 78%	895 1.08K	Previous Buy Current Buy	Get Alert
Nov 6, 2025	4.58%	Evan SeigermanBMO Capital 66%	930 1.1K	Previous Outperform Current Outperform	Get Alert
Oct 31, 2025	-6.35%	Carter GouldCantor Fitzgerald 63%	925 985	Previous Overweight Current Overweight	Get Alert
Oct 16, 2025	-9.87%	Seamus FernandezGuggenheim 82%	948 948	Previous Buy Current Buy	Get Alert
Oct 8, 2025	-9.87%	Seamus FernandezGuggenheim 82%	875 948	Previous Buy Current Buy	Get Alert
Oct 3, 2025	-2.74%	Terence FlynnMorgan Stanley 69%	1.02K 1.03K	Previous Overweight Current Overweight	Get Alert
Sep 17, 2025	-21.09%	Kerry HolfordBerenberg 48%	830 970	Previous Buy Current Hold	Get Alert
Sep 16, 2025	-0.17%	Chris SchottJP Morgan 65%	1.05K 1.1K	Previous Overweight Current Overweight	Get Alert
Aug 27, 2025	-33.45%	Rajesh KumarHSBC 54%	675 700	Previous Reduce Current Hold	Get Alert
Aug 13, 2025	-21.56%	Carter GouldCantor Fitzgerald 63%	825 975	Previous Overweight Current Overweight	Get Alert
Aug 13, 2025	-16.81%	Seamus FernandezGuggenheim 82%	875 942	Previous Buy Current Buy	Get Alert
Aug 11, 2025	-14.43%	James ShinDeutsche Bank 62%	900 1.01K	Previous Buy Current Buy	Get Alert
Aug 8, 2025	4.58%	Chris SchottJP Morgan 65%	1.1K 1.1K	Previous Overweight Current Overweight	Get Alert
Aug 8, 2025	-14.91%	Trung HuynhUBS 78%	895 1.05K	Previous Buy Current Buy	Get Alert
Jul 11, 2025	-10.44%	Seamus FernandezGuggenheim 82%	936 942	Previous Buy Current Buy	Get Alert
Jul 10, 2025	7.91%	Terence FlynnMorgan Stanley 69%	1.13K 1.14K	Previous Overweight Current Overweight	Get Alert
Jun 20, 2025	-11.01%	Seamus FernandezGuggenheim 82%	936 936	Previous Buy Current Buy	Get Alert
May 2, 2025	-0.17%	Trung HuynhUBS 78%	1.05K 1.1K	Previous Buy Current Buy	Get Alert
Apr 28, 2025	-33.45%	Rajesh KumarHSBC 54%	700 1.15K	Previous Buy Current Reduce	Get Alert
Apr 22, 2025	-7.3%	Carter GouldCantor Fitzgerald 63%	975	Previous Initiates Current Overweight	Get Alert
Apr 14, 2025	-11.77%	Seamus FernandezGuggenheim 82%	928 973	Previous Buy Current Buy	Get Alert
Apr 9, 2025	6.86%	Terence FlynnMorgan Stanley 69%	1.12K 1.15K	Previous Overweight Current Overweight	Get Alert
Apr 8, 2025	-15.57%	Asad Haider Goldman Sachs 64%	888 892	Previous Neutral Current Buy	Get Alert
Mar 5, 2025	4.58%	Mohit BansalWells Fargo 68%	970 1.1K	Previous Overweight Current Overweight	Get Alert
Feb 3, 2025	-1.31%	Srikripa DevarakondaTruist Securities 71%	1.03K 1.04K	Previous Buy Current Buy	Get Alert
Jan 28, 2025	-7.78%	Mohit BansalWells Fargo 68%	970 1K	Previous Overweight Current Overweight	Get Alert
Jan 28, 2025	13.14%	Peter VerdultCitigroup 28%	1.19K 1.25K	Previous Buy Current Buy	Get Alert
Dec 10, 2024	-5.21%	Tim AndersonB of A Securities 64%	997	Previous Current Buy	Get Alert
Nov 15, 2024	-4.92%	Alexandria HammondWolfe Research 62%	1K	Previous Initiates Current Outperform	Get Alert
Nov 4, 2024	-3.5%	James ShinDeutsche Bank 62%	1.01K 1.02K	Previous Buy Current Buy	Get Alert
Oct 31, 2024	-2.17%	Robyn KarnauskasTruist Securities 54%	1.03K 1.03K	Previous Buy Current Buy	Get Alert
Oct 31, 2024	-7.3%	Carter GouldBarclays 63%	975 1.02K	Previous Overweight Current Overweight	Get Alert
Oct 31, 2024	4.58%	Geoff MeachamB of A Securities 73%	1.1K 1.15K	Previous Buy Current Buy	Get Alert
Oct 25, 2024	18.84%	Peter VerdultCitigroup 28%	1.06K 1.25K	Previous Buy Current Buy	Get Alert
Oct 17, 2024	4.58%	—	1.1K	Previous Initiates Current Outperform	Get Alert
Oct 10, 2024	-1.79%	Srikripa DevarakondaTruist Securities 71%	1K 1.03K	Previous Buy Current Buy	Get Alert
Oct 3, 2024	-2.55%	James ShinDeutsche Bank 62%	1.02K 1.02K	Previous Buy Current Buy	Get Alert
Sep 16, 2024	-15.86%	Louise ChenCantor Fitzgerald 61%	885 885	Previous Overweight Current Overweight	Get Alert
Sep 13, 2024	4.58%	Chris SchottJP Morgan 65%	1.05K 1.1K	Previous Overweight Current Overweight	Get Alert
Sep 13, 2024	0.78%	Peter VerdultCitigroup 28%	1.06K	Previous Buy Current Buy	Get Alert
Sep 9, 2024	-15.86%	Louise ChenCantor Fitzgerald 61%	885 885	Previous Overweight Current Overweight	Get Alert
Aug 27, 2024	5.15%	Terence FlynnMorgan Stanley 69%	1.11K 1.11K	Previous Overweight Current Overweight	Get Alert
Aug 19, 2024	-15.86%	Louise ChenCantor Fitzgerald 61%	885 885	Previous Overweight Current Overweight	Get Alert
Aug 16, 2024	-2.07%	Seamus FernandezGuggenheim 82%	884 1.03K	Previous Buy Current Buy	Get Alert
Aug 14, 2024	-0.17%	Kerry HolfordBerenberg 48%	1K 1.05K	Previous Buy Current Buy	Get Alert
Aug 12, 2024	-2.55%	James ShinDeutsche Bank 62%	725 1.02K	Previous Hold Current Buy	Get Alert
Aug 9, 2024	-4.92%	Mohit BansalWells Fargo 68%	875 1K	Previous Overweight Current Overweight	Get Alert
Aug 9, 2024	4.68%	Evan SeigermanBMO Capital 66%	1K 1.1K	Previous Outperform Current Outperform	Get Alert
Aug 9, 2024	6.96%	Geoff MeachamB of A Securities 73%	1K 1.13K	Previous Buy Current Buy	Get Alert
Aug 5, 2024	-15.95%	Seamus FernandezGuggenheim 82%	855 884	Previous Buy Current Buy	Get Alert
Aug 5, 2024	-15.86%	Louise ChenCantor Fitzgerald 61%	885 885	Previous Overweight Current Overweight	Get Alert
Jul 24, 2024	-15.86%	Louise ChenCantor Fitzgerald 61%	885 885	Previous Overweight Current Overweight	Get Alert
Jul 15, 2024	-15.86%	Louise ChenCantor Fitzgerald 61%	885 885	Previous Overweight Current Overweight	Get Alert
Jul 11, 2024	-4.92%	Kerry HolfordBerenberg 48%	850 1K	Previous Buy Current Buy	Get Alert
Jul 11, 2024	-4.92%	Chris SchottJP Morgan 65%	900 1K	Previous Overweight Current Overweight	Get Alert
Jul 10, 2024	-2.55%	Carter GouldBarclays 63%	913 1.02K	Previous Overweight Current Overweight	Get Alert
Jul 5, 2024	-2.74%	Terence FlynnMorgan Stanley 69%	1.02K 1.02K	Previous Overweight Current Overweight	Get Alert
Jul 3, 2024	-4.83%	Evan SeigermanBMO Capital 66%	1K 1K	Previous Outperform Current Outperform	Get Alert
Jul 1, 2024	-15.86%	Louise ChenCantor Fitzgerald 61%	885 885	Previous Overweight Current Overweight	Get Alert
Jun 26, 2024	-15.86%	Louise ChenCantor Fitzgerald 61%	885 885	Previous Overweight Current Overweight	Get Alert
Jun 25, 2024	-15.86%	Louise ChenCantor Fitzgerald 61%	885 885	Previous Overweight Current Overweight	Get Alert
Jun 25, 2024	-4.92%	Srikripa DevarakondaTruist Securities 71%	892 1K	Previous Buy Current Buy	Get Alert
Jun 24, 2024	-3.5%	Akash TewariJefferies 52%	994 1.01K	Previous Buy Current Buy	Get Alert
Jun 24, 2024	-4.92%	Geoff MeachamB of A Securities 73%	1K 1K	Previous Buy Current Buy	Get Alert
Jun 24, 2024	-15.86%	Louise ChenCantor Fitzgerald 61%	885 885	Previous Overweight Current Overweight	Get Alert
Jun 20, 2024	-15.86%	Louise ChenCantor Fitzgerald 61%	885 885	Previous Overweight Current Overweight	Get Alert
Jun 17, 2024	-15.86%	Louise ChenCantor Fitzgerald 61%	885 885	Previous Overweight Current Overweight	Get Alert
Jun 12, 2024	-15.86%	Louise ChenCantor Fitzgerald 61%	885 885	Previous Overweight Current Overweight	Get Alert
Jun 11, 2024	-15.86%	Louise ChenCantor Fitzgerald 61%	885 885	Previous Overweight Current Overweight	Get Alert
Jun 7, 2024	-9.01%	Akash TewariJefferies 52%	925 957	Previous Buy Current Buy	Get Alert
May 14, 2024	-20.14%	David ToungArgus Research 68%	770 840	Previous Buy Current Buy	Get Alert
May 1, 2024	-4.83%	Evan SeigermanBMO Capital 66%	900 1K	Previous Outperform Current Outperform	Get Alert
May 1, 2024	-14.43%	Chris SchottJP Morgan 65%	850 900	Previous Overweight Current Overweight	Get Alert
May 1, 2024	-15.86%	Louise ChenCantor Fitzgerald 61%	815 885	Previous Overweight Current Overweight	Get Alert
May 1, 2024	-15.19%	Srikripa DevarakondaTruist Securities 71%	850 892	Previous Buy Current Buy	Get Alert
Apr 30, 2024	-15.86%	Louise ChenCantor Fitzgerald 61%	815 885	Previous Overweight Current Overweight	Get Alert
Apr 18, 2024	-22.51%	Louise ChenCantor Fitzgerald 61%	815 815	Previous Overweight Current Overweight	Get Alert
Apr 15, 2024	-22.51%	Louise ChenCantor Fitzgerald 61%	815 815	Previous Overweight Current Overweight	Get Alert
Apr 11, 2024	-31.26%	Chris ShibutaniGoldman Sachs 58%	650 723	Previous Neutral Current Neutral	Get Alert
Apr 5, 2024	-22.51%	Louise ChenCantor Fitzgerald 61%	815 815	Previous Overweight Current Overweight	Get Alert
Apr 3, 2024	—	Hans EngelErste Group 64%	—	Previous Hold Current Buy	Get Alert
Apr 2, 2024	-14.91%	Andrew BaumCitigroup 72%	675 895	Previous Buy Current Buy	Get Alert
Apr 1, 2024	-22.51%	Louise ChenCantor Fitzgerald 61%	815 815	Previous Overweight Current Overweight	Get Alert
Mar 22, 2024	-19.19%	Robyn KarnauskasTruist Securities 54%	850	Previous Buy Current Buy	Get Alert
Mar 15, 2024	-19.19%	Chris SchottJP Morgan 65%	775 850	Previous Overweight Current Overweight	Get Alert
Mar 1, 2024	-4.92%	Geoff MeachamB of A Securities 73%	800 1K	Previous Buy Current Buy	Get Alert
Feb 21, 2024	-22.04%	Elmar KrausDZ Bank 67%	820	Previous Buy Current Hold	Get Alert
Feb 20, 2024	-22.51%	Louise ChenCantor Fitzgerald 61%	815 815	Previous Overweight Current Overweight	Get Alert
Feb 16, 2024	-9.68%	Terence FlynnMorgan Stanley 69%	805 950	Previous Overweight Current Overweight	Get Alert

FAQ

What is the target price for Eli Lilly (LLY) stock?

The latest price target for Eli Lilly (NYSE:LLY) was reported by B of A Securities on December 15, 2025. The analyst firm set a price target for $1268.00 expecting LLY to rise to within 12 months (a possible 20.56% upside). 38 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Eli Lilly (LLY)?

The latest analyst rating for Eli Lilly (NYSE:LLY) was provided by B of A Securities, and Eli Lilly maintained their buy rating.

When was the last upgrade for Eli Lilly (LLY)?

The last upgrade for Eli Lilly and Co happened on November 10, 2025 when Leerink Partners raised their price target to $1104. Leerink Partners previously had a market perform for Eli Lilly and Co.

When was the last downgrade for Eli Lilly (LLY)?

The last downgrade for Eli Lilly and Co happened on November 10, 2025 when Freedom Capital Markets changed their price target from $750 to $950 for Eli Lilly and Co.

When is the next analyst rating going to be posted or updated for Eli Lilly (LLY)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Eli Lilly, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Eli Lilly was filed on December 15, 2025 so you should expect the next rating to be made available sometime around December 15, 2026.

Is the Analyst Rating Eli Lilly (LLY) correct?

While ratings are subjective and will change, the latest Eli Lilly (LLY) rating was a maintained with a price target of $1286.00 to $1268.00. The current price Eli Lilly (LLY) is trading at is $1051.80, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.